arrow_back Back Filing freshness 10-K FY 2026 SEC EDGAR

download Export Data

iBio, Inc.

IBIO

$1.20 ▼ -0.05 (-3.61%) at close

16 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

iBio, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $124.9M

Dividend Yield —

Revenue Growth -75.0% ↘

Op. Margin None

ROIC -41.0% ↗

FCF / Share $-0.23 ↗

Trailing P/E —

Price / Book 0.8x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 24, 2026.

16-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$100.00K

↓ -75.0% —

Net Income Profit after all expenses

$-33.04M

↓ -79.8% —

FCF / Share Free cash flow per share

$-0.23

↑ +84.3% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Financial Health ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2026 Jun 30, 2026 10-K ↗	FY 2025 Jun 30, 2025 10-K ↗	FY 2024 Jun 30, 2024 10-K ↗	FY 2023 Jun 30, 2023 10-K ↗	FY 2022 Jun 30, 2022 10-K ↗	FY 2021 Jun 30, 2021 10-K ↗	FY 2020 Jun 30, 2020 10-K ↗	FY 2019 Jun 30, 2019 10-K ↗	FY 2018 Jun 30, 2018 10-K ↗	FY 2017 Jun 30, 2017 10-K ↗	FY 2016 Jun 30, 2016 10-K ↗	FY 2015 Jun 30, 2015 10-K ↗	FY 2014 Jun 30, 2014 10-K ↗	FY 2013 Jun 30, 2013 10-K ↗	FY 2012 Jun 30, 2012 10-K ↗	FY 2011 Jun 30, 2011 10-K ↗
Revenue Growth YoY (%)	-75.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1038%)	77.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+872%)	—	N/M	0.5% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-94%)	44.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+459%)	-18.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-335%)	354.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4331%)	12.7% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+59%)	-58.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-830%)	-48.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-710%)	802.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+9937%)	-79.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1096%)	-21.1% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-364%)	—	—
EPS Growth YoY (%)	81.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	73.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	93.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	8.1% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	-92.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-79.8% Weak ↓ Weak Declining Year-over-year change in net income	26.2% Excellent ↑ Excellent Improving Year-over-year change in net income	61.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-29.2% Weak ↑ Weak Improving Year-over-year change in net income	-116.8% Weak ↓ Weak Declining Year-over-year change in net income	-41.2% Weak ↓ Weak Declining Year-over-year change in net income	6.6% Fair ↑ Fair Improving Year-over-year change in net income	-9.2% Weak ↑ Weak Improving Year-over-year change in net income	-10.8% Weak ↑ Weak Improving Year-over-year change in net income	-48.8% Weak ↓ Weak Declining Year-over-year change in net income	-47.4% Weak ↓ Weak Declining Year-over-year change in net income	-80.7% Weak ↓ Weak Declining Year-over-year change in net income	40.9% Excellent Excellent Year-over-year change in net income	-9.2% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	84.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	70.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	91.7% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	42.5% Excellent Excellent Year-over-year change in free cash flow	-14.9% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	-44.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-54.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	—	5.7% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	74.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	60.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	28.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-37.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	24.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-2.0% Weak Weak Compound annual revenue growth over 3 years	13.2% Good Good Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	-46.9% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-24.6% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-35.5% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	—	43.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	20.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-2.4% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	58.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-15.1% Weak Weak Compound annual revenue growth over 5 years	-21.0% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2026 Jun 30, 2026 10-K ↗	FY 2025 Jun 30, 2025 10-K ↗	FY 2024 Jun 30, 2024 10-K ↗	FY 2023 Jun 30, 2023 10-K ↗	FY 2022 Jun 30, 2022 10-K ↗	FY 2021 Jun 30, 2021 10-K ↗	FY 2020 Jun 30, 2020 10-K ↗	FY 2019 Jun 30, 2019 10-K ↗	FY 2018 Jun 30, 2018 10-K ↗	FY 2017 Jun 30, 2017 10-K ↗	FY 2016 Jun 30, 2016 10-K ↗	FY 2015 Jun 30, 2015 10-K ↗	FY 2014 Jun 30, 2014 10-K ↗	FY 2013 Jun 30, 2013 10-K ↗	FY 2012 Jun 30, 2012 10-K ↗	FY 2011 Jun 30, 2011 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	-360.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2501%)	—	—	—	—
Effective Tax Rate (%) (%)	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	-357.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3083%)	—	—	-444.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3804%)	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	-482.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-470.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.72x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.51x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.00x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.78x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.06x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2026 Jun 30, 2026 10-K ↗	FY 2025 Jun 30, 2025 10-K ↗	FY 2024 Jun 30, 2024 10-K ↗	FY 2023 Jun 30, 2023 10-K ↗	FY 2022 Jun 30, 2022 10-K ↗	FY 2021 Jun 30, 2021 10-K ↗	FY 2020 Jun 30, 2020 10-K ↗	FY 2019 Jun 30, 2019 10-K ↗	FY 2018 Jun 30, 2018 10-K ↗	FY 2017 Jun 30, 2017 10-K ↗	FY 2016 Jun 30, 2016 10-K ↗	FY 2015 Jun 30, 2015 10-K ↗	FY 2014 Jun 30, 2014 10-K ↗	FY 2013 Jun 30, 2013 10-K ↗	FY 2012 Jun 30, 2012 10-K ↗	FY 2011 Jun 30, 2011 10-K ↗
Return on Invested Capital (%)	-41.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-125.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-61.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-150.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-61.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-19.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-506.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-69.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-126.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-78.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-46.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-49.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-103.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-119.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-35.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-80.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-57.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-71.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-50.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-51.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-33.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-39.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-53.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-59.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-71.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-95.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-38.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-357%)	-123.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-923%)	-116.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-879%)	—	-79.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-628%)	-21.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-242%)	-29.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-294%)	—	-99.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-764%)	-163.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1187%)	-98.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-755%)	-59.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-493%)	-60.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-501%)	-122.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-915%)	-92.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-713%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2026 Jun 30, 2026 10-K ↗	FY 2025 Jun 30, 2025 10-K ↗	FY 2024 Jun 30, 2024 10-K ↗	FY 2023 Jun 30, 2023 10-K ↗	FY 2022 Jun 30, 2022 10-K ↗	FY 2021 Jun 30, 2021 10-K ↗	FY 2020 Jun 30, 2020 10-K ↗	FY 2019 Jun 30, 2019 10-K ↗	FY 2018 Jun 30, 2018 10-K ↗	FY 2017 Jun 30, 2017 10-K ↗	FY 2016 Jun 30, 2016 10-K ↗	FY 2015 Jun 30, 2015 10-K ↗	FY 2014 Jun 30, 2014 10-K ↗	FY 2013 Jun 30, 2013 10-K ↗	FY 2012 Jun 30, 2012 10-K ↗	FY 2011 Jun 30, 2011 10-K ↗
Interest Coverage (x)	-488.07x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-87.75x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-22.21x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-353.53x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-35.19x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-12.68x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-5.68x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.31x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7.43x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7.40x Weak Weak Operating income divided by interest expense Optimal: > 5x	-12.26x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-74.08x Weak Weak Operating income divided by interest expense Optimal: > 5x	-148.05x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-56.40M	$-8.58M	$-14.21M	$-4.30M	$-22.68M	$-77.40M	$-55.11M	$-4.42M	$-15.93M	$-8.09M	$-23.01M	$-9.49M	$-3.59M	$-4.41M	$-5.62M	$-2.84M

📊 What does each share earn? 6 metrics

Metric	FY 2026 Jun 30, 2026 10-K ↗	FY 2025 Jun 30, 2025 10-K ↗	FY 2024 Jun 30, 2024 10-K ↗	FY 2023 Jun 30, 2023 10-K ↗	FY 2022 Jun 30, 2022 10-K ↗	FY 2021 Jun 30, 2021 10-K ↗	FY 2020 Jun 30, 2020 10-K ↗	FY 2019 Jun 30, 2019 10-K ↗	FY 2018 Jun 30, 2018 10-K ↗	FY 2017 Jun 30, 2017 10-K ↗	FY 2016 Jun 30, 2016 10-K ↗	FY 2015 Jun 30, 2015 10-K ↗	FY 2014 Jun 30, 2014 10-K ↗	FY 2013 Jun 30, 2013 10-K ↗	FY 2012 Jun 30, 2012 10-K ↗	FY 2011 Jun 30, 2011 10-K ↗
Revenue per Share (USD)	$0.00	$0.04	$0.06	$0.00	$5.46	$6.06	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.32	$-1.75	$-6.50	$-106.20	$-115.60	$-60.00	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.23	$-1.46	$-4.90	$-59.08	$-102.76	$-89.42	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$1.54	$0.77	$2.47	$15.15	$145.49	$249.19	$202.10	$61.11	$503.92	$5.00K	$557.57	$727.35	$464.56	$446.98	$645.74	—
Tangible Book Value per Share (USD)	$1.51	$0.42	$1.85	$9.84	$134.37	$247.01	$198.02	$27.02	$453.43	$3.98K	$440.19	$574.51	$268.43	$207.70	$346.16	—
Basic Weighted Avg Shares (shares)	104.06M	10.50M	3.83M	612,250	436,050	391,250	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2026 Jun 30, 2026 10-K ↗	FY 2025 Jun 30, 2025 10-K ↗	FY 2024 Jun 30, 2024 10-K ↗	FY 2023 Jun 30, 2023 10-K ↗	FY 2022 Jun 30, 2022 10-K ↗	FY 2021 Jun 30, 2021 10-K ↗	FY 2020 Jun 30, 2020 10-K ↗	FY 2019 Jun 30, 2019 10-K ↗	FY 2018 Jun 30, 2018 10-K ↗	FY 2017 Jun 30, 2017 10-K ↗	FY 2016 Jun 30, 2016 10-K ↗	FY 2015 Jun 30, 2015 10-K ↗	FY 2014 Jun 30, 2014 10-K ↗	FY 2013 Jun 30, 2013 10-K ↗	FY 2012 Jun 30, 2012 10-K ↗	FY 2011 Jun 30, 2011 10-K ↗
Working Capital (USD)	$80.48M	$3.62M	$11.83M	$4.68M	$14.63M	$97.95M	$56.51M	$1.35M	$14.25M	$6.56M	$21.61M	$8.86M	$3.52M	$2.35M	$3.30M	—
Total Equity (USD)	$85.71M	$14.88M	$21.32M	$15.38M	$63.48M	$108.58M	$56.62M	$2.46M	$16.17M	$8.91M	$9.94M	$11.23M	$6.10M	$5.07M	$6.17M	$196.00K

📋 What is driving earnings? 4 metrics

Metric	FY 2026 Jun 30, 2026 10-K ↗	FY 2025 Jun 30, 2025 10-K ↗	FY 2024 Jun 30, 2024 10-K ↗	FY 2023 Jun 30, 2023 10-K ↗	FY 2022 Jun 30, 2022 10-K ↗	FY 2021 Jun 30, 2021 10-K ↗	FY 2020 Jun 30, 2020 10-K ↗	FY 2019 Jun 30, 2019 10-K ↗	FY 2018 Jun 30, 2018 10-K ↗	FY 2017 Jun 30, 2017 10-K ↗	FY 2016 Jun 30, 2016 10-K ↗	FY 2015 Jun 30, 2015 10-K ↗	FY 2014 Jun 30, 2014 10-K ↗	FY 2013 Jun 30, 2013 10-K ↗	FY 2012 Jun 30, 2012 10-K ↗	FY 2011 Jun 30, 2011 10-K ↗
Sales/Revenue/Turnover (USD)	$100.00K	$400.00K	$225.00K	$0.00	$2.38M	$2.37M	$1.64M	$2.02M	$444.00K	$394.00K	$948.00K	$1.85M	$205.00K	$1.01M	$1.28M	—
Depreciation Expense (USD)	$558.00K	$484.00K	$638.00K	$674.00K	$2.27M	$472.00K	$282.00K	$1.43M	$1.37M	$1.33M	$577.00K	$5.00K	$3.00K	$2.00K	$7.00K	—
Net Income, GAAP (USD)	$-33.04M	$-18.38M	$-24.91M	$-65.01M	$-50.30M	$-23.21M	$-16.44M	$-17.59M	$-16.11M	$-14.53M	$-9.76M	$-6.62M	$-3.67M	$-6.20M	$-5.68M	—
Operating Cash Flow (USD)	$-23.22M	$-15.30M	$-18.55M	$-30.44M	$-37.48M	$-30.06M	$-13.35M	$-13.97M	$-13.48M	$-13.16M	—	—	—	$-4.85M	$-6.01M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 16 years · 65 quarters

iBio, Inc.

Analytical Summary

16-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare IBIO with peers